Literature DB >> 11759084

Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci.

N Woodford1.   

Abstract

Five genotypes of acquired glycopeptide resistance have been documented in enterococci, with vanA and vanB being the most globally widespread and prevalent. Resistance results from the production of peptidoglycan precursors with reduced binding affinity for glycopeptides and is encoded by complex clusters of van genes. The prototype VanA element is Tn1546, a 10.8-kb transposon that carries the vanRSHAXYZ genes. Diverse VanA elements exist, but all share the vanRSHAX cluster and are believed to be derived from a Tn1546 progenitor. The sequences of these genes are remarkably conserved, with only a few point mutations identified. VanA elements do however vary by the presence of deletions and insertion sequences (IS) in nonessential genes (orf1, orf2, vanY, and vanZ) and intergenic regions. IS transposition probably plays a key role in VanA element evolution. By contrast, vanB gene clusters show greater sequence divergence. Three vanB alleles have been reported, of which vanB2 appears to be the most widespread, generally as part of Tn5382 and related elements. To date, only four Enterococcus faecium strains with VanD resistance have been reported, and each contained a distinct vanD allele. The VanE and VanG types have each been identified in single strains of Enterococcus faecalis. The existence of distinct genotypes, together with the allelic nature of vanB and vanD, suggests that van clusters have transferred to enterococci on multiple occasions from undefined donor species, with subsequent horizontal dissemination, particularly of VanA and VanB elements, among enterococci. Characterization of glycopeptide resistance elements yields information on their evolution and broadens our insights into the epidemiology of resistant enterococci.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11759084     DOI: 10.1089/10766290152652774

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  16 in total

1.  Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.

Authors:  Paige M Fox; Russell J Lampen; Katrina S Stumpf; Gordon L Archer; Michael W Climo
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 2.  Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine.

Authors:  Peter E Reynolds; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  First nosocomial outbreak of vancomycin-resistant Enterococcus faecium expressing a VanD-like phenotype associated with a vanA genotype.

Authors:  Thierry Naas; Nicolas Fortineau; Renaud Snanoudj; Colette Spicq; Antoine Durrbach; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora.

Authors:  M-C Domingo; A Huletsky; R Giroux; K Boissinot; F J Picard; P Lebel; M J Ferraro; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010.

Authors:  Rodrigo E Mendes; Leah N Woosley; David J Farrell; Helio S Sader; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2011-12-19       Impact factor: 5.191

6.  Methicillin-resistant Staphylococcus aureus (MRSA) as a cause of nosocomial wound infections.

Authors:  Maida Sisirak; Amra Zvizdic; Mirsada Hukic
Journal:  Bosn J Basic Med Sci       Date:  2010-02       Impact factor: 3.363

7.  Outbreak of vancomycin-susceptible Enterococcus faecium containing the wild-type vanA gene.

Authors:  Tom A Szakacs; Lindsay Kalan; Michael J McConnell; Alireza Eshaghi; Dea Shahinas; Allison McGeer; Gerry D Wright; Donald E Low; Samir N Patel
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

8.  Recombination in the genome of Chlamydia trachomatis involving the polymorphic membrane protein C gene relative to ompA and evidence for horizontal gene transfer.

Authors:  João P Gomes; William J Bruno; Maria J Borrego; Deborah Dean
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

9.  Enterococcus gallinarum N04-0414 harbors a VanD-type vancomycin resistance operon and does not contain a D-alanine:D-alanine 2 (ddl2) gene.

Authors:  David A Boyd; Mark A Miller; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

Review 10.  VanD-type vancomycin-resistant Enterococcus faecium 10/96A.

Authors:  Florence Depardieu; Peter E Reynolds; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.